GENERAL
Kenya Launches Long-Acting HIV Prevention Drug
Kenya has launched a new, long-acting HIV prevention drug, Lenacapavir, offering a six-month injection regimen that is over 99.9% effective. This initiative aims to simplify prevention and bolster the national fight against HIV, especially as the country faces challenges with reduced international aid.